Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06815107

Risk Factors for Poor Tolerance of Ureteral Double-J Stent

Led by Centre Hospitalier Universitaire, Amiens · Updated on 2025-02-07

200

Participants Needed

1

Research Sites

311 weeks

Total Duration

On this page

Sponsors

C

Centre Hospitalier Universitaire, Amiens

Lead Sponsor

C

Centre Hospitalier d'Abbeville

Collaborating Sponsor

AI-Summary

What this Trial Is About

The placement of a Ureteral Double-J Stent as an emergency treatment or preparation for endoscopy after Colic nephritis is very frequent. It is often poorly supported, most often by young patients. A rich symptomatology is related to the probe responsible for a limitation of activities that can have a strong socio-economic impact. The objective of this study is the identification of the predictive factors of poor tolerance.

CONDITIONS

Official Title

Risk Factors for Poor Tolerance of Ureteral Double-J Stent

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient over 18 years old
  • Patient who needs Ureteral Double-J Stenting
Not Eligible

You will not qualify if you...

  • Patient under 18 years old
  • Iterative change of stent
  • Understanding disorder
  • Inability to answer the questionnaire
  • Patient refusal
  • Long-term Ureteral Double-J Stenting (more than 6 months)
  • Active cancer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHU Amiens-Picardie

Amiens, France, 80054

Actively Recruiting

Loading map...

Research Team

P

Philippe De Sousa, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here